GOLDSTONE ASIA PHARM.(300434)
Search documents
金石亚药(300434) - 2025 Q4 - 年度业绩预告
2026-01-28 09:15
Financial Projections - The company expects a net profit of approximately 118.91 million yuan for the year 2025, representing a year-on-year growth of 29.58%[4] - The net profit after deducting non-recurring gains and losses is projected to be around 97.90 million yuan, reflecting an 18.96% increase compared to the previous year[4] Profit Drivers - The increase in profit is attributed to the successful commercialization of R&D results in the new materials and machinery sectors, as well as a rise in sales of anti-influenza virus products due to market demand[6] - Non-recurring gains and losses are expected to impact net profit by approximately 21.01 million yuan[6] Operational Efficiency - The company has implemented effective budget optimization and cost control measures to support improved operating performance[6] Financial Reporting - The financial data presented is preliminary and will be detailed in the 2025 annual report, pending audit by the accounting firm[7]
金石亚药(300434.SZ):目前公司真空镀膜设备暂未涉及太空光伏设备制造领域
Ge Long Hui· 2026-01-27 08:16
Core Viewpoint - The company Jinshi Yaya (300434.SZ) has indicated that its vacuum coating equipment is not currently involved in the manufacturing of space photovoltaic equipment, but it plans to continue exploring research and collaboration opportunities for vacuum coating technology in other fields [1] Group 1 - The company is currently not engaged in the space photovoltaic equipment manufacturing sector [1] - Future plans include deepening the exploration of vacuum coating technology in various other fields [1]
金石亚药(300434.SZ):目前,公司未开展涉及可控核聚变方面的业务
Ge Long Hui· 2026-01-19 15:35
格隆汇1月19日丨金石亚药(300434.SZ)在投资者互动平台表示,目前,公司未开展涉及可控核聚变方面 的业务。 ...
金石亚药(300434.SZ):全资子公司取得高新技术企业证书和专精特新中小企业证书
Ge Long Hui A P P· 2026-01-15 12:37
Core Viewpoint - The company Jinshi Yiyao (300434.SZ) announced that its wholly-owned subsidiary, Zhejiang Di'er Pharmaceutical Co., Ltd. (referred to as "Di'er Pharmaceutical"), has been recognized as a high-tech enterprise and a specialized and innovative small and medium-sized enterprise [1] Group 1 - Di'er Pharmaceutical received the "High-tech Enterprise Certificate" issued by the National Taxation Bureau of Zhejiang Province, with a certificate number GR202533006871, valid for three years from December 19, 2025 [1] - The company also obtained the "Zhejiang Province Specialized and Innovative Small and Medium-sized Enterprise Honor Certificate," which is valid from December 2025 to December 2028 [1]
金石亚药:全资子公司取得高新技术企业证书和专精特新中小企业证书
Ge Long Hui· 2026-01-15 12:17
格隆汇1月15日丨金石亚药(300434.SZ)公布,公司之全资二级子公司浙江迪耳药业有限公司(简称"迪 耳药业")被认定为高新技术企业和专精特新中小企业。近日,迪耳药业分别收到了国家税务总局浙江 省税务局、浙江省财政厅、浙江省经济和信息化厅联合下发的《高新技术企业证书》(证书编号: GR202533006871,发证时间:2025年12月19日,有效期:三年)和浙江省经济和信息化厅下发的《浙 江省专精特新中小企业荣誉证书》(有效期:2025年12月至2028年12月)。 ...
金石亚药:迪耳药业被认定为高新技术企业和专精特新中小企业
Mei Ri Jing Ji Xin Wen· 2026-01-15 11:43
每经头条(nbdtoutiao)——不到20万元,就能买特斯拉了?"廉价版"Model 3或进入中国市场,续航里 程480公里!关于自动驾驶,美国市场也有大调整 (记者 曾健辉) 每经AI快讯,金石亚药1月15日晚间发布公告称,四川金石亚洲医药股份有限公司之全资二级子公司浙 江迪耳药业有限公司被认定为高新技术企业和专精特新中小企业。 ...
金石亚药:子公司获高新技术企业证书
Xin Lang Cai Jing· 2026-01-15 11:34
金石亚药公告,全资子公司近日取得高新技术企业证书和专精特新中小企业证书。这标志着子公司在技 术创新和专业化发展方面得到认可,有助于提升公司的市场竞争力和品牌影响力。 ...
金石亚药(300434) - 关于全资子公司取得高新技术企业证书和专精特新中小企业证书的公告
2026-01-15 11:26
四川金石亚洲医药股份有限公司 关于全资子公司取得高新技术企业证书和 证券代码:300434 证券简称:金石亚药 公告编号:2026-001 根据《中华人民共和国企业所得税法》《中华人民共和国企业所得税法实施 条例》的有关规定,通过高新技术企业认定后,迪耳药业自获得高新技术企业认 定后的连续三年内,将享受国家关于高新技术企业的相关优惠政策,即按 15%的 税率计缴企业所得税。 上述两项证书的取得不会对公司当期经营业绩产生重大影响,敬请广大投资 者理性投资,注意防范投资风险。 特此公告。 四川金石亚洲医药股份有限公司 董 事 会 二〇二六年一月十五日 专精特新中小企业证书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 四川金石亚洲医药股份有限公司(以下简称"公司")之全资二级子公司浙 江迪耳药业有限公司(以下简称"迪耳药业")被认定为高新技术企业和专精特 新中小企业。 近日,迪耳药业分别收到了国家税务总局浙江省税务局、浙江省财政厅、浙 江省经济和信息化厅联合下发的《高新技术企业证书》(证书编号: GR202533006871,发证时间:2025 年 12 ...
金石亚药:公司重点推广的石油、天然气工业用带式增强柔性复合管成套设备,国内外销售订单稳步上升
Mei Ri Jing Ji Xin Wen· 2025-12-29 01:13
金石亚药(300434.SZ)12月29日在投资者互动平台表示,公司自成立以来一直致力于增强塑料复合管 道全套生产工艺、技术解决方案及成套生产设备的研发、制造,为客户提供整厂方案规划、优质的设备 和服务,推动细分行业有序、健康、高质量发展。公司复合管道可应用于市政给排水、工业压力输送管 道、矿用耐磨管道、石油天然气集输管线等多种民用工业领域。近年来,公司重点推广的石油、天然气 工业用带式增强柔性复合管成套设备,以先进稳定的制造工艺和设备铆定国际市场并带动国内的应用试 点。2025年,该品类产品国内外的销售订单稳步上升,市场预期持续向好。 每经AI快讯,有投资者在投资者互动平台提问:公司的复合管道应用哪些领域?有没有量产? (文章来源:每日经济新闻) ...
金石亚药:复合管道应用于市政给排水、工业压力输送等多领域,2025年销售订单稳步上升
Sou Hu Cai Jing· 2025-12-29 01:05
Core Viewpoint - The company is focused on enhancing the production processes and technological solutions for composite pipes, aiming to provide comprehensive solutions for various industrial applications, particularly in the oil and gas sector [1]. Group 1: Company Focus and Applications - The company has been dedicated to the research and manufacturing of complete production processes and equipment for plastic composite pipes since its establishment [1]. - Composite pipes can be applied in various fields including municipal water supply and drainage, industrial pressure transmission, mining wear-resistant pipes, and oil and gas gathering pipelines [1]. - The company is particularly promoting its belt-reinforced flexible composite pipe equipment for the oil and gas industry, which is expected to gain traction in both domestic and international markets [1]. Group 2: Market Outlook - Sales orders for the company's products in the oil and gas sector are anticipated to steadily increase by 2025, with positive market expectations continuing [1].